Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1989 1
1991 3
1992 1
1993 6
1994 2
1995 11
1996 8
1997 3
1998 8
1999 7
2000 6
2001 11
2002 7
2003 7
2004 15
2005 8
2006 4
2007 8
2008 8
2009 3
2010 8
2011 5
2012 8
2013 6
2014 1
2015 7
2016 3
2017 4
2018 6
2019 10
2020 5
2021 1
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Diffuse panbronchiolitis.
Kudoh S, Keicho N. Kudoh S, et al. Clin Chest Med. 2012 Jun;33(2):297-305. doi: 10.1016/j.ccm.2012.02.005. Epub 2012 Mar 31. Clin Chest Med. 2012. PMID: 22640847 Review.
Diffuse panbronchiolitis (DPB) is characterized by chronic airway infection with diffuse bilateral micronodular pulmonary lesions. ...
Diffuse panbronchiolitis (DPB) is characterized by chronic airway infection with diffuse bilateral micronodular pulmonary lesi …
Diffuse panbronchiolitis.
Poletti V, Casoni G, Chilosi M, Zompatori M. Poletti V, et al. Eur Respir J. 2006 Oct;28(4):862-71. doi: 10.1183/09031936.06.00131805. Eur Respir J. 2006. PMID: 17012632 Free article. Review.
Diffuse panbronchiolitis (DPB) is an idiopathic inflammatory disease, well recognised in Japan and principally affecting the respiratory bronchioles, causing a progressive suppurative and severe obstructive respiratory disorder. ...
Diffuse panbronchiolitis (DPB) is an idiopathic inflammatory disease, well recognised in Japan and principally affecting the r …
Diffuse panbronchiolitis.
Keng LT, Lee MR. Keng LT, et al. Postgrad Med J. 2019 Mar;95(1121):175. doi: 10.1136/postgradmedj-2018-136091. Epub 2018 Nov 29. Postgrad Med J. 2019. PMID: 30498005 No abstract available.
Anti-inflammatory effects of medications used for viral infection-induced respiratory diseases.
Yamaya M, Kikuchi A, Sugawara M, Nishimura H. Yamaya M, et al. Respir Investig. 2023 Mar;61(2):270-283. doi: 10.1016/j.resinv.2022.11.002. Epub 2022 Dec 19. Respir Investig. 2023. PMID: 36543714 Free PMC article. Review.
Respiratory viruses like rhinovirus, influenza virus, respiratory syncytial virus, and coronavirus cause several respiratory diseases, such as bronchitis, pneumonia, pulmonary fibrosis, and coronavirus disease 2019, and exacerbate bronchial asthma, chronic obstructive pulmonary d …
Respiratory viruses like rhinovirus, influenza virus, respiratory syncytial virus, and coronavirus cause several respiratory diseases, such …
Macrolides for diffuse panbronchiolitis.
Lin X, Lu J, Yang M, Dong BR, Wu HM. Lin X, et al. Cochrane Database Syst Rev. 2015 Jan 25;1(1):CD007716. doi: 10.1002/14651858.CD007716.pub4. Cochrane Database Syst Rev. 2015. PMID: 25618845 Free PMC article. Review.
BACKGROUND: Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. ...The primary outcomes were five-year survival rate, lung function and clinical response. We used risk ratios (RR) for individual trial result …
BACKGROUND: Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. ...The primary ou …
Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
Bush A. Bush A. Paediatr Respir Rev. 2020 Apr;34:67-74. doi: 10.1016/j.prrv.2019.07.002. Epub 2019 Aug 16. Paediatr Respir Rev. 2020. PMID: 31629643 Review.
The first clinical indication of non-antibiotic benefits of macrolides was in the Far East, in adults with diffuse panbronchiolitis. ...Case reports, case series and some randomised controlled trials followed in other conditions. Three trials of azithr …
The first clinical indication of non-antibiotic benefits of macrolides was in the Far East, in adults with diffuse panbronc …
Macrolides for diffuse panbronchiolitis.
Yang M, Dong BR, Lu J, Lin X, Wu HM. Yang M, et al. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007716. doi: 10.1002/14651858.CD007716.pub3. Cochrane Database Syst Rev. 2013. PMID: 23450579 Updated. Review.
BACKGROUND: Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. ...The primary outcomes were five-year survival rate, lung function and clinical response. We used risk ratios (RR) for individual trial result …
BACKGROUND: Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. ...The primary ou …
Diffuse panbronchiolitis-The response and recurrence after erythromycin therapy.
Chuang MC, Chou YT, Lin YC, Hsieh MJ, Tsai YH. Chuang MC, et al. J Formos Med Assoc. 2016 Oct;115(10):876-882. doi: 10.1016/j.jfma.2015.09.006. Epub 2015 Dec 15. J Formos Med Assoc. 2016. PMID: 26705139 Free article.
BACKGROUND/PURPOSE: Diffuse panbronchiolitis (DPB) is a rare clinicopathological entity. ...Clinical, radiological, and laboratory parameters were analyzed, and the course and outcome of erythromycin treatment were examined. ...
BACKGROUND/PURPOSE: Diffuse panbronchiolitis (DPB) is a rare clinicopathological entity. ...Clinical, radiological, and …
Genetic predisposition to diffuse panbronchiolitis.
Keicho N, Hijikata M. Keicho N, et al. Respirology. 2011 May;16(4):581-8. doi: 10.1111/j.1440-1843.2011.01946.x. Respirology. 2011. PMID: 21303426 Review.
Diffuse panbronchiolitis is characterized by chronic inflammation in respiratory bronchioles and sinobronchial infection. ...Until the establishment of long-term macrolide therapy, the prognosis was generally poor. Case studies of diffuse panbronchiolitis …
Diffuse panbronchiolitis is characterized by chronic inflammation in respiratory bronchioles and sinobronchial infection. ...U …
Macrolides for diffuse panbronchiolitis.
Yang M, Dong BR, Lu J, Lin X, Wu HM. Yang M, et al. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD007716. doi: 10.1002/14651858.CD007716.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154381 Updated. Review.
BACKGROUND: Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. ...The primary outcomes were five-year survival rate, lung function and clinical response. We used risk ratios (RR) for individual trial result …
BACKGROUND: Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. ...The primary ou …
185 results